Hanmei Li
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 9
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems 5
- Molecular Medicine top 10%
- Immunology top 10%
- Immunotherapy and Immune Responses 4
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 8
-
- RNA Interference and Gene Delivery 7
- Advanced biosensing and bioanalysis techniques 5
-
- Alzheimer's disease research and treatments 4
-
- Polymer Surface Interaction Studies 4
In The Last Decade
Hanmei Li
63 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Biomaterials 563
- Pharmaceutical Science 254
- Molecular Medicine 70
- Immunology 296
- Biomedical Engineering 550
Countries citing papers authored by Hanmei Li
This map shows the geographic impact of Hanmei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanmei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanmei Li more than expected).
Fields of papers citing papers by Hanmei Li
This network shows the impact of papers produced by Hanmei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanmei Li. The network helps show where Hanmei Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hanmei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 12 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 16 | |
| 6 | 2024 | 22 | |
| 7 | 2024 | 2 | |
| 8 | Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseasesbreakdown → | 2024 | 75 |
| 9 | 2024 | 15 | |
| 10 | 2024 | 7 | |
| 11 | 2024 | 20 | |
| 12 | 2024 | 2 | |
| 13 | 2023 | 42 | |
| 14 | 2023 | 36 | |
| 15 | 2023 | 34 | |
| 16 | 2023 | 4 | |
| 17 | 2022 | 11 | |
| 18 | 2022 | 20 | |
| 19 | 2017 | 115 | |
| 20 | 2016 | 41 |
About Hanmei Li
Hanmei Li is a scholar working on Pharmaceutical Science, Biomaterials and Surfaces, Coatings and Films, having authored 66 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (8 papers), RNA Interference and Gene Delivery (7 papers), Advanced Drug Delivery Systems (5 papers), Advanced biosensing and bioanalysis techniques (5 papers), Immunotherapy and Immune Responses (4 papers), Alzheimer's disease research and treatments (4 papers) and Polymer Surface Interaction Studies (4 papers). The work is most often cited by research in Biomaterials (563 citations), Pharmaceutical Science (254 citations) and Molecular Medicine (70 citations). Hanmei Li has collaborated with scholars based in China, Germany and Macao. Frequent co-authors include Liang Zou, Tao Gong, Dan Yin, Qiang Peng, Qi Tang, Zhirong Zhang, Huile Gao, Sonja Krstin, Michaël Wink and Wei Li.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.